Welcome to LookChem.com Sign In|Join Free
  • or
Benzonitrile, 2-chloro-4-[[1-(3-cyclopenten-1-ylmethyl)-4-piperidinyl]oxy]-3-methyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

867219-46-3

Post Buying Request

867219-46-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

867219-46-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 867219-46-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,2,1 and 9 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 867219-46:
(8*8)+(7*6)+(6*7)+(5*2)+(4*1)+(3*9)+(2*4)+(1*6)=203
203 % 10 = 3
So 867219-46-3 is a valid CAS Registry Number.

867219-46-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-4-{[1-(cyclopent-3-en-1-ylmethyl)piperidin-4-yl]oxy}-3-methylbenzonitrile

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:867219-46-3 SDS

867219-46-3Relevant academic research and scientific papers

NOVEL PIPERIDINE DERIVATIVES

-

Page/Page column 29, (2010/11/25)

The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.

PIPERIDINE DERIVATES FOR THE TREATMENT OF CHEMOKINES MEDIARED DISEASE

-

Page/Page column 28, (2010/02/14)

The present invention provides a compound of a formula (I) wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 867219-46-3